Earnings NewsHealthcareSinovac Biotech reports Q4 resultsApr. 22, 2021 10:54 PM ETSinovac Biotech Ltd. (SVA) StockBy: SA News Team Sinovac Biotech (NASDAQ:SVA): Q4 GAAP EPS of $0.96. Revenue of $327.5M (+303.8% Y/Y) Press Release Recommended For YouMore Trending NewsSee More »Related StocksSymbolLast Price% ChgSVA--Sinovac Biotech Ltd.Trending AnalysisTrending News